URETERIC DILATATION

This adverse event was reported 276 times

URETERIC DILATATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Lipid Emulsion [EPC] 1 0.0004
1 Anthelmintic [EPC] 1 0.0003
2 Quinolone Antimicrobial [EPC] 3 0.0003
3 Rifamycin Antimycobacterial [EPC] 1 0.0003
4 Bispecific CD20-directed CD3 T Cell Engager [EPC] 1 0.0002
5 Lipid-based Polyene Antifungal [EPC] 3 0.0002
6 Progestin Antagonist [EPC] 1 0.0002
7 Antimalarial [EPC] 2 0.0002
8 Antiprotozoal [EPC] 2 0.0002
9 Progesterone [EPC] 4 0.0002
See all drug classes enriched for association with URETERIC DILATATION